Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

BioMarin Manufacturing Ireland, a subsidiary of BioMarin Pharmaceutical Inc.,announced that it expects to expand its Dublin operation, according to IDA Ireland, the economic development agency of Ireland. The Dublin operation has responsibility for...

Watson Laboratories, Inc, a subsidiary of the generic-drug company Actavis plc, has filed suit against FDA, challenging the agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex®...

Reckitt Benckiser, which reported earlier this week that it was in discussions with Merck & Co. for Merck's over-the-counter business, issued a statement on April 30, 2014, to say "it is no longer in active discussion regarding an offer for...

GlaxoSmithKline plc (GSK) has received FDA approval for Incruse™ Ellipta® (umeclidinium) as an anticholinergic indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary...

Novartis has received FDA approval for its new molecular entity, Zykadia (ceritinib), for treating patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).   Zykadia is an oral anaplastic lymphoma kinase...

Bristol-Myers Squibb Company has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological...

Pfizer Inc. confirmed on April 28, 2014 of its interest in a possible merger transaction with AstraZeneca despite AstraZeneca's assertion that it wishes to remain an independent company. Pfizer Chairman and CEO Ian Read outlined...